Does anyone know what the dosage would be? 40mg daily? Or less if pinning it?
Yea I saw that after. but nobody has it for injection & the suppliers in china don't yet have the injectable. they are missing out on big $$$ though. so many of us with a genetic predisposition to high LDL would go on it right away!It's a PCSK9 inhibitor and you wouldn't pin it. This is the oral version of the injectable that's already available. The injectable is crazy expensive, so this would be a huge win for both convenience and cost.
In phase 2 studies they tested these dosages: 6, 12, 18, or 30 mg once daily. All showed clinically meaningful reductions of LDL-C and ApoB w/ >55% placebo-adjusted reduction observed at doses of 12 mg and higher. MK-0616 was well tolerated and there were no overall trends in AEs across treatment groups
They're in phase 3 now, targeting a 20mg dose.
Yeah, evolocumab is by far the most effective drug I've tried for lipid control. About 30% and 50% reduction in LDL and Triglycerides switching from statin. But it's costly even with good insurance and it's a royal pain getting reapproved every year because insurers suck.Yea I saw that after. but nobody has it for injection & the suppliers in china don't yet have the injectable. they are missing out on big $$$ though. so many of us with a genetic predisposition to high LDL would go on it right away!
I'm curious if retatrutide lipid effects will be additive with Repatha or if Reta acts through the same PCSK9 inhibition pathway with minimal added improvement. I may find out in a couple months.